A Novel Function of Extraerythrocytic Hemoglobin

Summary

Following wounding, the surrounding fibroblasts migrate towards the clotted blood in the wounded space to form granulation tissue resulting in wound repair. One of the most abundant proteins in the wound is hemoglobin (Hb). The aim of the present study was to examine the effect of Hb on fibroblasts in producing components of the plasminogen-plasmin system which play an important role in wound healing. Human Hb Ao added to cultures of human fibroblasts elicited a dose-dependent increase in fibrinolytic activity. ELISA demonstrated an increased fibrinolytic activity due to increased urokinase-type plasminogen activator (uPA). An increase in tissue-type PA was also detected, while the type-1 PA inhibitor level remained unaffected. Globin showed a similar effect, while hemin and protoporphyrin IX exerted no effect. The influence of Hb was quenched when haptoglobin was added. Although northern blot analysis revealed no difference in uPA transcripts between stimulated and non-stimulated cells, immunopretipitation experiments confirmed an increased uPA synthesis in Hb- and globin-treated cells, suggesting that enhanced expression is achieved through translational regulation. These findings suggest a potential role for globin in modulating cellular functions during the process of wound healing.

Keywords

Hemoglobin - globin - wound healing - the plasminogen-plasmin system - fibrinolytic system - plasminogen activator

• References

• 1 Kwaan HC. The biologic role of components of the plasminogen-plasmin system. Prog Cardiovas Dis 1992; 34: 309-16.
• 2 Danø K, Rømer J, Nielsen BS, Bjorn S, Pyke C, Rygaard J, Lund LR. Cancer invasion and tissue remodeling-cooperation of prtease systems and cell types. APMIS 1999; 107: 120-7.
• 3 Kirchheimer JC, Wojita J, Christ G, Binder BR. Proliferation of a human epidermal tumor cell line stimulated by urokinase. FASEB J 1987; 1: 125-8.
• 4 Collen D. The plasminogen (fibrinolytic) system. Thromb Haemost 1999; 82: 259-70.
• 5 Del Rosso M, Fibbi G, Matucci Cernic M. The urokinase-type plasminogen activator system and inflammatory joint diseases. Clin Exp Rheumatol 1999; 17: 485-98.
• 6 Blasi F. Proteolysis, cell adhesion, chemotaxis and invasiveness are regulated by the uPA-uPAR-PAI-1 system. Thromb Haemost 1999; 82: 298-304.
• 7 Andreasen PA, Egelund R, Petersen HH. The plasminogen activation system in tumor growth, invasion and metastasis. Cell Mol Life Sci 2000; 57: 25-40.
• 8 Grøndahl-Hansen J, Lund LR, Ralfkiaer E, Ottevanger V, Danø K. Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo. J Invest Dermatol 1988; 90: 790-5.
• 9 Rømer J, Lund LR, Eriksen J, Ralfkiaer E, Zeheb R, Gelehrter TD, Danø K. Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds. J Invest Dermatol 1991; 97: 803-11.
• 10 Schefer BM, Maier K, Eickhoff U, Todd RF, Kramer MD. Plasminogen activation in healing human wounds. Am J Pathol 1994; 144: 1269-80.
• 11 Pawar S, Kartha S, Toback FG. Differential gene expression in migrating renal epithelial cells after wounding. J Cell Physiol 1995; 165: 556-65.
• 12 Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, DeVos R, van den Oord JJ, Collen D, Mulligan R. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994; 368: 419-24.
• 13 Rømer J, Bugge TH, Pyke C, Lund LR, Flick MJ, Degen JL, Danø K. Impaired wound haling in mice with a disrupted plasminogen gene. Nat Med 1996; 2: 287-92.
• 14 Carmeliet P, Moons L, Lijnen R, Janssens S, Lupu F, Collen D, Gerard RD. Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice. Circulation 1997; 96: 3180-91.
• 15 Carmeliet P, Moons L, Dewerchin M, Rosenberg S, Herbert JM, Lupu F, Collen D. Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice. J Cell Biol 1998; 140: 233-45.
• 16 Creemers E, Cleutjens J, Smits J, Heymans S, Moons L, Collen D, Daemen M, Carmeliet P. Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. Am J Pathol 2000; 156: 1865-73.
• 17 Huisman THJ. Separation of hemoglobins and hemoglobin chains by high-performance liquid chromatography. J Chromatogr 1987; 418: 277-304.
• 18 Yoshida E, Verrusio EN, Mihara H, Oh DY, Kwaan HC. Enhancement of the expression of urokinase-type plasminogen activator from PC-3 human prostate cancer cells by thrombin. Cancer Res 1994; 54: 3300-4.
• 19 Everse J, Johnson MC, Marini MA. Peroxidative activities of hemoglobin and hemoglobin derivatives. Method Enzymol 1994; 231: 547-61.
• 20 Zilletti L, Ciuffi M, Franchi-Micheli S, Fusi F, Gentilini G, Moneti G, Valoti M, Sgaragli GP. Cyclooxygenase activity of hemoglobin. Method Enzymol 1994; 231: 562-72.
• 21 Everse J, Hsia N. The toxicities of native and modified hemoglobins. Free Radic Biol Med 1997; 22: 1075-99.
• 22 Elkins C. Identification and purification of a conserved heme-regulated hemoglobin-binding outer membrane protein from Haemophilus ducreyi. Infect Immun 1995; 63: 1241-5.
• 23 Lewis LA, Dyer DW. Identification of an iron-regulated outer membrane protein of Neisseria meningitidis involved in the utilization of hemoglobin complexed to haptoglobin. J Bacteriol 1995; 177: 1299-306.
• 24 Chen C, Sparling F, Lewis LW, Dyer DW, Elkins C. Identification and purification of a hemoglobin-binding outer membrane protein from Neisseria gonorrhoeae. Infect Immunol 1996; 64: 5008-14.
• 25 Schally AV, Baba Y, Nair RMG. The amino acid sequence of a peptide with growth hormone-releasing activity isolated from porcine hypothalamus. J Biol Chem 1971; 246: 6647-50.
• 26 Ivanov VT, Karelin AA, Philoppova MM, Nazimov IV, Pletnev VZ. Hemoglobin as a source of endogenous bioactive peptides: The concept of tissue-specific peptide pool. Biopoly 1997; 43: 171-88.
• 27 Galoyan AA. Primary structure and biological activity of hemoglobin-related hypothalamic peptides. Biopoly 1975; 43: 135-7.